Subtopic Deep Dive
Economic Burden of Surgical Site Infections
Research Guide
What is Economic Burden of Surgical Site Infections?
Economic Burden of Surgical Site Infections quantifies the attributable costs from prolonged hospitalization, readmissions, treatments, and excess mortality associated with SSIs in surgical patients.
Studies match SSI patients to controls to isolate excess length of stay and costs, as in Kirkland et al. (1999) with 1700 citations reporting extra hospitalization and costs. European estimates aggregate SSI incidence and economic impacts across countries (Leaper et al., 2004, 321 citations). Hospital-level analyses predict savings from SSI elimination (Jenks et al., 2013, 316 citations). Over 20 key papers span 1999-2018.
Why It Matters
Quantifying SSI costs justifies prevention investments; Kirkland et al. (1999) found SSIs added $12,987 per case in 1990s dollars through excess stays. Jenks et al. (2013) projected £1 million annual savings for one English hospital by eliminating SSIs. Leaper et al. (2004) estimated €3-10 billion yearly EU burden, informing policy for bundles like those in Anderson et al. (2014). Engemann et al. (2003) showed MRSA SSIs doubled costs versus MSSA, guiding antimicrobial stewardship.
Key Research Challenges
Attributable Cost Isolation
Matching SSI cases to controls is needed to separate infection effects from comorbidities, as Kirkland et al. (1999) used one-to-one matching. Confounders like patient frailty complicate estimates (Korol et al., 2013). Few studies adjust for surgery complexity.
Regional Cost Variability
SSI burdens differ by income level; Bhangu et al. (2018) compared high/middle/low-income countries in a multicentre cohort. Leaper et al. (2004) noted incomplete European data. Standardizing costs across currencies and systems remains unresolved.
MRSA Cost Premium Measurement
MRSA SSIs increase length of stay and costs over MSSA, per Engemann et al. (2003) analyzing 479 patients. Resistance patterns evolve, requiring updated models. Long-term readmission costs are understudied.
Essential Papers
The Impact of Surgical-Site Infections in the 1990s: Attributable Mortality, Excess Length of Hospitalization, And Extra Costs
Kathryn B. Kirkland, Jane Briggs, Sharon L. Trivette et al. · 1999 · Infection Control and Hospital Epidemiology · 1.7K citations
Abstract Objective: To determine mortality, morbidity, and costs attributable to surgical-site infections (SSIs) in the 1990s. Design: A matched follow-up study of a cohort of patients with SSI, ma...
Adverse Clinical and Economic Outcomes Attributable to Methicillin Resistance among Patients with<i>Staphylococcus aureus</i>Surgical Site Infection
John J. Engemann, Yehuda Carmeli, Sara E. Cosgrove et al. · 2003 · Clinical Infectious Diseases · 933 citations
Data for 479 patients were analyzed to assess the impact of methicillin resistance on the outcomes of patients with Staphylococcus aureus surgical site infections (SSIs). Patients infected with met...
Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study
Aneel Bhangu, Adesoji Ademuyiwa, María Lorena Aguilera et al. · 2018 · The Lancet Infectious Diseases · 461 citations
A Systematic Review of Risk Factors Associated with Surgical Site Infections among Surgical Patients
Ellen Korol, Karissa Johnston, Nathalie Waser et al. · 2013 · PLoS ONE · 427 citations
In a broad review of published literature, risk factors for SSI were characterized as describing reduced fitness, patient frailty, surgery duration, and complexity. Recognition of risk factors freq...
Strategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update
Deverick J. Anderson, Kelly Podgorny, Sandra I. Berríos-Torres et al. · 2014 · Infection Control and Hospital Epidemiology · 362 citations
Previously published guidelines are available that provide comprehensive recommendations for detecting and preventing healthcare-associated infections (HAIs). The intent of this document is to high...
Surgical site infection – a European perspective of incidence and economic burden
David Leaper, Harry van Goor, J. Reilly et al. · 2004 · International Wound Journal · 321 citations
Abstract This retrospective review of reported surgical site infection (SSI) rates in Europe was undertaken to obtain an estimated scale of the problem and the associated economic burden. Prelimina...
Clinical and economic burden of surgical site infection (SSI) and predicted financial consequences of elimination of SSI from an English hospital
Peter J. Jenks, Marc Laurent, S. McQuarry et al. · 2013 · Journal of Hospital Infection · 316 citations
Reading Guide
Foundational Papers
Start with Kirkland et al. (1999, 1700 citations) for matched cohort methods isolating excess LOS/costs; follow with Engemann et al. (2003, 933 citations) on MRSA impacts and Leaper et al. (2004, 321 citations) for European scale.
Recent Advances
Bhangu et al. (2018, 461 citations) for global incidence/costs; Jenks et al. (2013, 316 citations) for elimination projections; Anderson et al. (2014, 362 citations) links burdens to prevention bundles.
Core Methods
Matched case-control for attribution (Kirkland 1999); systematic reviews of risks/costs (Korol 2013); multicentre cohorts (Bhangu 2018); hospital financial modeling (Jenks 2013).
How PapersFlow Helps You Research Economic Burden of Surgical Site Infections
Discover & Search
Research Agent uses searchPapers on 'SSI economic burden Kirkland' to retrieve the 1999 paper (1700 citations), then citationGraph reveals Engemann et al. (2003) and Leaper et al. (2004) as highly cited descendants. exaSearch scans 250M+ papers for global cost studies, while findSimilarPapers expands to Jenks et al. (2013).
Analyze & Verify
Analysis Agent applies readPaperContent to Kirkland et al. (1999) extracting $12,987 excess cost, then runPythonAnalysis with pandas recomputes attributable costs from matched cohort tables. verifyResponse (CoVe) cross-checks claims against Jenks et al. (2013), with GRADE grading SSIs as moderate evidence for high-burden procedures.
Synthesize & Write
Synthesis Agent detects gaps like post-2018 low-income costs via contradiction flagging across Bhangu et al. (2018). Writing Agent uses latexEditText for cost tables, latexSyncCitations for Kirkland/Engemann refs, and latexCompile for a prevention ROI report; exportMermaid diagrams cost attribution flows.
Use Cases
"Extract and plot excess LOS/costs from Kirkland 1999 SSI cohort data"
Research Agent → searchPapers → Analysis Agent → readPaperContent + runPythonAnalysis (pandas/matplotlib barplot of matched LOS/costs) → researcher gets CSV-exported stats with p-values.
"Write LaTeX cost-effectiveness analysis citing Kirkland, Jenks, Leaper"
Synthesis Agent → gap detection → Writing Agent → latexEditText (draft) → latexSyncCitations (10 refs) → latexCompile → researcher gets PDF with formatted tables/figures.
"Find code/models for SSI cost simulation from related papers"
Research Agent → paperExtractUrls on Jenks 2013 → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets Python scripts for hospital-level SSI elimination forecasts.
Automated Workflows
Deep Research workflow runs systematic review: searchPapers (SSI costs) → citationGraph → 50+ papers → structured report with GRADE-scored costs from Kirkland/Engemann. DeepScan applies 7-step analysis to Bhangu et al. (2018) with CoVe checkpoints on income-level burdens. Theorizer generates ROI models from Jenks/Leaper data flows.
Frequently Asked Questions
What is the definition of economic burden in SSI research?
Economic burden quantifies SSI-attributable costs like excess hospitalization ($12,987/case, Kirkland et al. 1999), readmissions, and treatments beyond matched controls.
What methods quantify SSI costs?
Matched cohort studies (Kirkland et al. 1999) compare SSI vs non-SSI patients; hospital audits (Jenks et al. 2013) model elimination savings; multicentre cohorts (Bhangu et al. 2018) adjust for global settings.
What are key papers on SSI economic burden?
Kirkland et al. (1999, 1700 citations) on US costs/mortality; Engemann et al. (2003, 933 citations) on MRSA premiums; Leaper et al. (2004, 321 citations) on €3-10B EU burden; Jenks et al. (2013, 316 citations) on UK hospital savings.
What open problems exist in SSI cost research?
Post-2018 data from low-income settings (Bhangu et al. 2018 flags gaps); long-term societal costs beyond hospitals; dynamic models for evolving resistance (Engemann et al. 2003).
Research Surgical site infection prevention with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Economic Burden of Surgical Site Infections with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers